Before a new drug or medical device can be tested on humans in clinical trials, it must be tested thoroughly in preclinical trials to make sure it is safe and effective. The preclinical period is the most arduous, the phase where many prospective products fail (often due to unrecognized pitfalls in the regulatory process), finding the right research organization is essential. Not only does a sponsoring organization need to enlist the services of a staff knowledgeable in cutting-edge science and technology, well-versed in the ins and outs of governmental and industry regulations and best practices, but find one with a proven track record and a reliably clear and concise communication style. Sarani Biointegra Private limited possesses these qualities; we assist you with preclinical research services that proceed to clinical trials in a timely manner.
Sarani Biointegra Private limited has the infrastructure, harmonized protocols, and advanced technologies to conduct pre-clinical trials, accelerate your time to screen the drug candidates and identify the potential ones with their molecular mechanism of action, thereby minimizing risks of late phase failure. It all begins with our end-to-end approach from using appropriate cell lines to study the end point pertaining to the biological action. Biomarkers specific to each biological condition would be used to study the mechanism of action, using high throughput in vitro assays and modern molecular biology tools and techniques. These in vitro assays would help in identifying the potential candidates to be explored further for formulation and clinical trials. Thus, Sarani Biointegra Private limited is committed to entire journey of early drug development.